Cargando…

Healthcare costs attributable to abnormal weight in China: evidence based on a longitudinal study

BACKGROUND: The prevalence of abnormal weight is on the rise, presenting serious health risks and socioeconomic problems. Nonetheless, there is a lack of studies on the medical cost savings that can be attained through the mitigation of abnormal weight. The aim of this study was to estimate the impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shiqi, Xu, Xinpeng, You, Hua, Ge, Jinjin, Wu, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552200/
https://www.ncbi.nlm.nih.gov/pubmed/37798694
http://dx.doi.org/10.1186/s12889-023-16855-6
_version_ 1785115909168300032
author Zhao, Shiqi
Xu, Xinpeng
You, Hua
Ge, Jinjin
Wu, Qifeng
author_facet Zhao, Shiqi
Xu, Xinpeng
You, Hua
Ge, Jinjin
Wu, Qifeng
author_sort Zhao, Shiqi
collection PubMed
description BACKGROUND: The prevalence of abnormal weight is on the rise, presenting serious health risks and socioeconomic problems. Nonetheless, there is a lack of studies on the medical cost savings that can be attained through the mitigation of abnormal weight. The aim of this study was to estimate the impact of abnormal weight on healthcare costs in China. METHODS: The study employed a 4-wave panel data from China Family Panel Studies (CFPS) between 2012 and 2018 (11,209 participants in each wave). Inpatient, non-inpatient and total healthcare costs were outcome variables. Abnormal weight is categorized based on body mass index (BMI). Initially, the two-part model was employed to investigate the impact of overweight/obesity and underweight on healthcare utilisation and costs, respectively. Subsequently, the estimated results were utilised to calculate the overweight/obesity attributable fraction (OAF) and the underweight attributable fraction (UAF). RESULTS: In 2018, healthcare costs per person for overweight and obese population were estimated to be $607.51 and $639.28, respectively, and the underweight population was $755.55. In comparison to people of normal weight, individuals who were overweight/obese (OR = 1.067, p < 0.05) was more likely to utilise healthcare services. Overweight/obesity attributable fraction (OAF) was 3.90% of total healthcare costs and 4.31% of non-inpatient costs. Overweight/obesity does not result in additional healthcare expenditures for young people but increases healthcare costs for middle-aged adults (OAF = 7.28%) and older adults (OAF = 6.48%). The non-inpatient cost of underweight population was significantly higher than that of normal weight population (β = 0.060,p < 0.1), but the non-inpatient health service utilisation was not significantly affected. CONCLUSIONS: Abnormal weight imposes a huge economic burden on individuals, households and the society. Abnormal weight in Chinese adults significantly increased healthcare utilisation and costs, particular in non-inpatient care. It is recommended that government and relevant social agencies provide a better social environment to enhance individual self-perception and promote healthy weight.
format Online
Article
Text
id pubmed-10552200
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105522002023-10-06 Healthcare costs attributable to abnormal weight in China: evidence based on a longitudinal study Zhao, Shiqi Xu, Xinpeng You, Hua Ge, Jinjin Wu, Qifeng BMC Public Health Research BACKGROUND: The prevalence of abnormal weight is on the rise, presenting serious health risks and socioeconomic problems. Nonetheless, there is a lack of studies on the medical cost savings that can be attained through the mitigation of abnormal weight. The aim of this study was to estimate the impact of abnormal weight on healthcare costs in China. METHODS: The study employed a 4-wave panel data from China Family Panel Studies (CFPS) between 2012 and 2018 (11,209 participants in each wave). Inpatient, non-inpatient and total healthcare costs were outcome variables. Abnormal weight is categorized based on body mass index (BMI). Initially, the two-part model was employed to investigate the impact of overweight/obesity and underweight on healthcare utilisation and costs, respectively. Subsequently, the estimated results were utilised to calculate the overweight/obesity attributable fraction (OAF) and the underweight attributable fraction (UAF). RESULTS: In 2018, healthcare costs per person for overweight and obese population were estimated to be $607.51 and $639.28, respectively, and the underweight population was $755.55. In comparison to people of normal weight, individuals who were overweight/obese (OR = 1.067, p < 0.05) was more likely to utilise healthcare services. Overweight/obesity attributable fraction (OAF) was 3.90% of total healthcare costs and 4.31% of non-inpatient costs. Overweight/obesity does not result in additional healthcare expenditures for young people but increases healthcare costs for middle-aged adults (OAF = 7.28%) and older adults (OAF = 6.48%). The non-inpatient cost of underweight population was significantly higher than that of normal weight population (β = 0.060,p < 0.1), but the non-inpatient health service utilisation was not significantly affected. CONCLUSIONS: Abnormal weight imposes a huge economic burden on individuals, households and the society. Abnormal weight in Chinese adults significantly increased healthcare utilisation and costs, particular in non-inpatient care. It is recommended that government and relevant social agencies provide a better social environment to enhance individual self-perception and promote healthy weight. BioMed Central 2023-10-05 /pmc/articles/PMC10552200/ /pubmed/37798694 http://dx.doi.org/10.1186/s12889-023-16855-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhao, Shiqi
Xu, Xinpeng
You, Hua
Ge, Jinjin
Wu, Qifeng
Healthcare costs attributable to abnormal weight in China: evidence based on a longitudinal study
title Healthcare costs attributable to abnormal weight in China: evidence based on a longitudinal study
title_full Healthcare costs attributable to abnormal weight in China: evidence based on a longitudinal study
title_fullStr Healthcare costs attributable to abnormal weight in China: evidence based on a longitudinal study
title_full_unstemmed Healthcare costs attributable to abnormal weight in China: evidence based on a longitudinal study
title_short Healthcare costs attributable to abnormal weight in China: evidence based on a longitudinal study
title_sort healthcare costs attributable to abnormal weight in china: evidence based on a longitudinal study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552200/
https://www.ncbi.nlm.nih.gov/pubmed/37798694
http://dx.doi.org/10.1186/s12889-023-16855-6
work_keys_str_mv AT zhaoshiqi healthcarecostsattributabletoabnormalweightinchinaevidencebasedonalongitudinalstudy
AT xuxinpeng healthcarecostsattributabletoabnormalweightinchinaevidencebasedonalongitudinalstudy
AT youhua healthcarecostsattributabletoabnormalweightinchinaevidencebasedonalongitudinalstudy
AT gejinjin healthcarecostsattributabletoabnormalweightinchinaevidencebasedonalongitudinalstudy
AT wuqifeng healthcarecostsattributabletoabnormalweightinchinaevidencebasedonalongitudinalstudy